1. Home
  2. PTPI

PTPI

Petros Pharmaceuticals Inc.

Logo Petros Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 11:33am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.

Founded: 2020 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 4.8M IPO Year: N/A
Target Price: $4.00 AVG Volume (30 days): 974.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.35 EPS Growth: N/A
52 Week Low/High: $0.81 - $9.54 Next Earning Date: 05-13-2024
Revenue: $5,822,388 Revenue Growth: -2.83%
Revenue Growth (this year): -0.76% Revenue Growth (next year): 0.09%

Share on Social Networks: